HUP0203921A2 - Diazepin-karboxamid-származékok, eljárás a vegyületek előállítására, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk - Google Patents
Diazepin-karboxamid-származékok, eljárás a vegyületek előállítására, ezeket tartalmazó gyógyszerkészítmények és alkalmazásukInfo
- Publication number
- HUP0203921A2 HUP0203921A2 HU0203921A HUP0203921A HUP0203921A2 HU P0203921 A2 HUP0203921 A2 HU P0203921A2 HU 0203921 A HU0203921 A HU 0203921A HU P0203921 A HUP0203921 A HU P0203921A HU P0203921 A2 HUP0203921 A2 HU P0203921A2
- Authority
- HU
- Hungary
- Prior art keywords
- compounds
- group
- alkyl
- carboxamide
- preparation
- Prior art date
Links
- -1 Carboxamide diazepin derivatives Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000007529 inorganic bases Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 150000007530 organic bases Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A találmány (I) általános képletű vegyületekre vonatkozik, ahol R1<>jelentése -C(O)-R5, -SO2-R5 vagy -C(O)-NR6R5 általános képletűcsoport, ahol R5 jelentése alkil-, cikloalkil-, fenil-, naftil- vagyheterociklusos csoport, R6 jelentése hidrogénatom vagy alkilcsoport,R2 és R7 jelentése pedig olyan, hogy vagy R7 jelentése hidrogénatom ésR2 jelentése természetes vagy nem természetes aminosavból származócsoport, vagy R2 és R7 a kapcsolódó nitrogén- és szénatommal együttgyűrűt alkot, R3 jelentése -CH=N2 vagy -CH2L-R4 általános képletűcsoport; R4 jelentése alkil- vagy karbociklusos vagy heterociklusoscsoport, L jelentése vegyértékkötés vagy kétértékű oxigén-, nitrogén-vagy kénatomot tartalmazó csoport és szerves vagy szervetlen savakkalvagy szerves vagy szervetlen bázisokkal alkotott addíciós sóik. Atalálmány a vegyületek előállítására szolgáló eljárást és a vegyületekgyógyszerként történő alkalmazását is magában foglalja, továbbákiterjed a vegyületeket tartalmazó gyógyszerkészítményekre is. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9916567A FR2802927B1 (fr) | 1999-12-28 | 1999-12-28 | Nouveaux derives de diazepine carboxamide, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et leur nouvelle utilisation |
| PCT/FR2000/003622 WO2001047930A1 (fr) | 1999-12-28 | 2000-12-21 | Derives de diazepine carboxamide, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et leur utilisation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0203921A2 true HUP0203921A2 (hu) | 2003-03-28 |
| HUP0203921A3 HUP0203921A3 (en) | 2005-01-28 |
Family
ID=9553901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0203921A HUP0203921A3 (en) | 1999-12-28 | 2000-12-21 | Carboxamide diazepin derivatives, preparation method, pharmaceutical compositions containing them and use thereof |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1246824B1 (hu) |
| JP (1) | JP2003519152A (hu) |
| KR (1) | KR20020062772A (hu) |
| AT (1) | ATE268775T1 (hu) |
| AU (1) | AU780522B2 (hu) |
| BR (1) | BR0016845A (hu) |
| CA (1) | CA2395275A1 (hu) |
| DE (1) | DE60011473T2 (hu) |
| DK (1) | DK1246824T3 (hu) |
| EA (1) | EA005288B1 (hu) |
| EE (1) | EE200200362A (hu) |
| ES (1) | ES2218275T3 (hu) |
| FR (1) | FR2802927B1 (hu) |
| HR (1) | HRP20020558A2 (hu) |
| HU (1) | HUP0203921A3 (hu) |
| IL (1) | IL150419A0 (hu) |
| MX (1) | MXPA02006413A (hu) |
| NO (1) | NO20023107L (hu) |
| NZ (1) | NZ519884A (hu) |
| PL (1) | PL355950A1 (hu) |
| PT (1) | PT1246824E (hu) |
| SI (1) | SI1246824T1 (hu) |
| SK (1) | SK9092002A3 (hu) |
| WO (1) | WO2001047930A1 (hu) |
| YU (1) | YU47502A (hu) |
| ZA (1) | ZA200205221B (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220115062A (ko) | 2021-02-09 | 2022-08-17 | (주)오스티오뉴로젠 | 크로몬 구조의 화합물을 포함하는 골다공증의 예방 및 치료용 약학적 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| US5552400A (en) * | 1994-06-08 | 1996-09-03 | Sterling Winthrop Inc. | Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors |
| US5847135A (en) * | 1994-06-17 | 1998-12-08 | Vertex Pharmaceuticals, Incorporated | Inhibitors of interleukin-1β converting enzyme |
-
1999
- 1999-12-28 FR FR9916567A patent/FR2802927B1/fr not_active Expired - Fee Related
-
2000
- 2000-12-21 AU AU26888/01A patent/AU780522B2/en not_active Ceased
- 2000-12-21 BR BR0016845-9A patent/BR0016845A/pt not_active IP Right Cessation
- 2000-12-21 EE EEP200200362A patent/EE200200362A/xx unknown
- 2000-12-21 WO PCT/FR2000/003622 patent/WO2001047930A1/fr not_active Application Discontinuation
- 2000-12-21 KR KR1020027008366A patent/KR20020062772A/ko not_active Application Discontinuation
- 2000-12-21 ES ES00990087T patent/ES2218275T3/es not_active Expired - Lifetime
- 2000-12-21 CA CA002395275A patent/CA2395275A1/fr not_active Abandoned
- 2000-12-21 EP EP00990087A patent/EP1246824B1/fr not_active Expired - Lifetime
- 2000-12-21 SK SK909-2002A patent/SK9092002A3/sk unknown
- 2000-12-21 HU HU0203921A patent/HUP0203921A3/hu unknown
- 2000-12-21 NZ NZ519884A patent/NZ519884A/en unknown
- 2000-12-21 MX MXPA02006413A patent/MXPA02006413A/es active IP Right Grant
- 2000-12-21 AT AT00990087T patent/ATE268775T1/de not_active IP Right Cessation
- 2000-12-21 PL PL00355950A patent/PL355950A1/xx not_active Application Discontinuation
- 2000-12-21 YU YU47502A patent/YU47502A/sh unknown
- 2000-12-21 JP JP2001549400A patent/JP2003519152A/ja not_active Abandoned
- 2000-12-21 DK DK00990087T patent/DK1246824T3/da active
- 2000-12-21 SI SI200030455T patent/SI1246824T1/xx unknown
- 2000-12-21 IL IL15041900A patent/IL150419A0/xx unknown
- 2000-12-21 EA EA200200721A patent/EA005288B1/ru not_active IP Right Cessation
- 2000-12-21 PT PT00990087T patent/PT1246824E/pt unknown
- 2000-12-21 DE DE60011473T patent/DE60011473T2/de not_active Expired - Fee Related
-
2002
- 2002-06-27 NO NO20023107A patent/NO20023107L/no not_active Application Discontinuation
- 2002-06-27 HR HR20020558A patent/HRP20020558A2/hr not_active Application Discontinuation
- 2002-06-28 ZA ZA200205221A patent/ZA200205221B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL355950A1 (en) | 2004-05-31 |
| ZA200205221B (en) | 2003-09-04 |
| IL150419A0 (en) | 2002-12-01 |
| KR20020062772A (ko) | 2002-07-29 |
| AU2688801A (en) | 2001-07-09 |
| ATE268775T1 (de) | 2004-06-15 |
| HUP0203921A3 (en) | 2005-01-28 |
| AU780522B2 (en) | 2005-03-24 |
| EP1246824A1 (fr) | 2002-10-09 |
| PT1246824E (pt) | 2004-10-29 |
| NO20023107L (no) | 2002-08-27 |
| EA005288B1 (ru) | 2004-12-30 |
| FR2802927A1 (fr) | 2001-06-29 |
| SK9092002A3 (en) | 2003-04-01 |
| SI1246824T1 (en) | 2004-10-31 |
| WO2001047930A1 (fr) | 2001-07-05 |
| DE60011473T2 (de) | 2005-06-30 |
| MXPA02006413A (es) | 2002-11-29 |
| EE200200362A (et) | 2003-08-15 |
| CA2395275A1 (fr) | 2001-07-05 |
| FR2802927B1 (fr) | 2002-03-01 |
| YU47502A (sh) | 2005-03-15 |
| NO20023107D0 (no) | 2002-06-27 |
| BR0016845A (pt) | 2002-10-15 |
| NZ519884A (en) | 2005-03-24 |
| HRP20020558A2 (en) | 2004-02-29 |
| ES2218275T3 (es) | 2004-11-16 |
| JP2003519152A (ja) | 2003-06-17 |
| DK1246824T3 (da) | 2004-10-18 |
| EP1246824B1 (fr) | 2004-06-09 |
| DE60011473D1 (de) | 2004-07-15 |
| EA200200721A1 (ru) | 2002-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK419086A (da) | Heterocykliske substituerede indoler, mellemprodukter, fremgangsmaader til fremstilling heraf og laegemidler | |
| HUP0302962A2 (hu) | Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása | |
| FI883744A (fi) | Menetelmä valmistaa farmaseuttisesti käyttökelpoisia indolijohdoksia | |
| HUP0002050A2 (hu) | Szubsztituált imidazolvegyületek, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| TW368501B (en) | 7-(2-aminoethyl)-benzothiazolones | |
| HUT70194A (en) | Quinoline- or quinazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
| ATE56449T1 (de) | Neue beta-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel (h). | |
| DE69910083D1 (de) | Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten | |
| MXPA01013148A (es) | Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico. | |
| HUP0203921A2 (hu) | Diazepin-karboxamid-származékok, eljárás a vegyületek előállítására, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DE3574471D1 (de) | 1,6-naphthyridin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel. | |
| PT1021404E (pt) | Derivados de azetidinona para o tratamento de infeccoes pelo hcmv | |
| DE3880861D1 (de) | 1-dethia-2-thia-cephalosporansaeurederivate, verfahren zur herstellung, ihre verwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen. | |
| DE59309898D1 (de) | 4-oxo-azetidin-2-sulfonsäureamide und ihre salze, verfahren zu deren herstellung und ihre verwendung | |
| ATE229495T1 (de) | Verfahren zur herstellung von n-acyl- aminosäureestern und n-acyl-aminoacetalen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |